With subsequent in vitro cell culture studies demonstrating sensitization to DNA replication checkpoint inhibition, this AML outlier group defined by APOBEC3A expression may serve as an important link between clonal hematopoiesis, malignant transformation, and therapeutic approach.186. This evidence concerns the gene APOBEC3A and acute myeloid leukemia.